Aided by COVID-19 Funding, Firms Continued Developing Handheld Diagnostic Instruments in 2022
The lightweight, portable instruments coming onto the market employ promise to deliver test results closer to patients, potentially hastening treatments.
Becton Dickinson Gets CE-IVD Mark for BD Max Combined COVID, Flu, RSV Panel
The firm also plans to submit the assay to the US Food and Drug Administration for Emergency Use Authorization in the coming weeks.
A handful of firms have announced they are developing at-home combo kits that can detect and differentiate COVID-19, flu A, and B on current testing platforms.
Luminex Obtains CE Marking for MDx Panel to Detect Flu A/B, RSV, COVID-19
Results are generated in a single workflow from a patient sample, which enables rapid detection for the differential diagnosis of a single pathogen.
The firm expects to establish a US-based development and manufacturing footprint for its multiplex PCR assay kits.